|
US4775536A
(en)
|
1986-02-24 |
1988-10-04 |
Bristol-Myers Company |
Enteric coated tablet and process for making
|
|
US5292522A
(en)
|
1989-06-20 |
1994-03-08 |
Rohm Gmbh |
Aqueous film coating agent for solid medicaments
|
|
US5047258A
(en)
|
1989-07-14 |
1991-09-10 |
Sterling Drug Inc. |
Aqueous spray-coating process
|
|
US6623759B2
(en)
|
1996-06-28 |
2003-09-23 |
Astrazeneca Ab |
Stable drug form for oral administration with benzimidazole derivatives as active ingredient and process for the preparation thereof
|
|
DE19631084A1
(de)
|
1996-08-01 |
1998-02-05 |
Basf Ag |
Verwendung von (Meth)acrylsäure-Copolymeren zur Erhöhung der Permeabilität der Schleimhaut
|
|
US6312728B1
(en)
|
1998-07-07 |
2001-11-06 |
Cascade Development, Inc. |
Sustained release pharmaceutical preparation
|
|
DE69924735T2
(de)
|
1998-07-28 |
2006-01-19 |
Tanabe Seiyaku Co., Ltd. |
Zur wirkstoffabgabe an zielorten im darm fähige zubereitung
|
|
US20040028737A1
(en)
|
2002-08-12 |
2004-02-12 |
Kopran Research Laboratories Limited |
Enteric coated stable oral pharmaceutical composition of acid unstable drug and process for preparing the same
|
|
DE10260919A1
(de)
|
2002-12-20 |
2004-07-01 |
Röhm GmbH & Co. KG |
Verfahren zur Herstellung von überzogenen Arzneiformen und Nahrungsergänzungsmitteln mit Konzentrationsgradienten im Überzug
|
|
US20070065513A1
(en)
|
2003-10-31 |
2007-03-22 |
Avi Avramoff |
Stable lansoprazole formulation
|
|
US9149439B2
(en)
|
2005-03-21 |
2015-10-06 |
Sandoz Ag |
Multi-particulate, modified-release composition
|
|
DE102005032806A1
(de)
|
2005-07-12 |
2007-01-18 |
Röhm Gmbh |
Verwendung eines teilneutralisierten, anionischen (Meth)acrylat-Copolymers als Überzug für die Herstellung einer Arzneiform mit einer Wirkstofffreisetzung bei erniedrigten pH-Werten
|
|
WO2010124855A1
(en)
*
|
2009-04-30 |
2010-11-04 |
Actogenix Nv |
Cryoprotectants for freeze drying of lactic acid bacteria
|
|
CA2903375C
(en)
|
2013-03-01 |
2020-11-24 |
Bpsi Holdings, Llc. |
Delayed release film coatings containing calcium silicate and substrates coated therewith
|
|
TWI812624B
(zh)
|
2017-06-14 |
2023-08-21 |
南韓商希杰生物科技股份有限公司 |
包含細菌品系之組成物
|
|
MA51770A
(fr)
*
|
2017-07-05 |
2020-05-13 |
Evelo Biosciences Inc |
Compositions et méthodes de traitement du cancer à l'aide de bifidobacterium animalis ssp. lactis
|
|
GB2564481B
(en)
*
|
2017-07-14 |
2019-10-23 |
4D Pharma Leon S L U |
Process
|
|
EP3749340A1
(en)
*
|
2018-02-06 |
2020-12-16 |
Evelo Biosciences, Inc. |
Compositions and methods for treating cancer and immune disorders using veillonella bacteria
|
|
JP7012840B2
(ja)
*
|
2018-05-31 |
2022-01-28 |
ベルテクス株式会社 |
乳酸菌及びその用途
|
|
EP3801578B1
(en)
|
2018-06-07 |
2023-08-30 |
Artugen Therapeutics Ltd. |
B. amyloliquefaciens strain and therapeutic use
|
|
WO2020120714A1
(en)
|
2018-12-12 |
2020-06-18 |
4D Pharma Research Limited |
Compositions comprising bacterial strains
|
|
IT201900006056A1
(it)
*
|
2019-04-18 |
2020-10-18 |
Probiotical Spa |
Procedimento per la preparazione di una biomassa di cellule di batteri liofilizzate stabili e determinazione della loro stabilità mediante un metodo citofluorimetrico
|
|
JP7797208B2
(ja)
*
|
2019-06-21 |
2026-01-13 |
エヴェロ バイオサイエンシズ，インコーポレーテッド |
プレボテラ（Ｐｒｅｖｏｔｅｌｌａ）を使用してＴＨ２媒介性状態を処置する組成物及び方法
|
|
CN110251474B
(zh)
*
|
2019-07-15 |
2022-01-07 |
北京工商大学 |
一种淀粉基大肠靶向双层益生菌片的制备方法
|
|
WO2021252861A1
(en)
*
|
2020-06-11 |
2021-12-16 |
Evelo Biosciences, Inc. |
Compositions and methods for treating diseases and disorders using megasphaera sp
|